BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14534014)

  • 1. [Diagnosis and treatment of differentiated thyroid carcinoma].
    Mora J
    Rev Esp Med Nucl; 2003; 22(5):349-59; quiz 360-2. PubMed ID: 14534014
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.
    Franceschi M; Kusić Z; Franceschi D; Lukinac L; Roncević S
    J Nucl Med; 1996 Mar; 37(3):446-51. PubMed ID: 8772642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
    Dottorini ME; Vignati A; Mazzucchelli L; Lomuscio G; Colombo L
    J Nucl Med; 1997 May; 38(5):669-75. PubMed ID: 9170425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up of thyroid cancer patients with favorable prognostic indicators.
    Leboulleux S; Baudin E; Schlumberger M
    Ann Endocrinol (Paris); 2003 Feb; 64(1):64-7. PubMed ID: 12707639
    [No Abstract]   [Full Text] [Related]  

  • 5. Papillary and follicular thyroid carcinoma.
    Schlumberger MJ; Torlantano M
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):601-13. PubMed ID: 11289737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Controversies in the follow-up and management of well-differentiated thyroid cancer. New answers to old questions].
    Abós Olivares MD; Pesquera González C
    Rev Esp Med Nucl; 2005; 24(3):207-15. PubMed ID: 15847791
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer.
    Mariani G; Ferdeghini M; Augeri C; Villa G; Taddei GZ; Scopinaro G; Boni G; Bodei L; Rabitti C; Molinari E; Bianchi R
    Cancer Biother Radiopharm; 2000 Apr; 15(2):211-7. PubMed ID: 10803328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differentiated thyroid cancers].
    Gorgone S; Campennì A; Calbo E; Catalfamo A; Sciglitano P; Sofia L; Niceta M; Borzì R; Calbo L
    G Chir; 2009; 30(1-2):26-9. PubMed ID: 19272228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
    J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic follicular thyroid carcinoma to the kidney: a case report.
    Garcia-Sanchis L; Lopez-Aznar D; Oltra A; Rivas A; Alonso J; Montalar J; Mateo A
    Clin Nucl Med; 1999 Jan; 24(1):48-50. PubMed ID: 9890493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual presentations of differentiated thyroid cancer: analysis of 55 cases from North India.
    Bhansali A; Dutta P; Reddy KS; Masoodi SR; Radotra BD; Kumar V; Mittal BR
    Ann Saudi Med; 2005; 25(5):428-32. PubMed ID: 16270771
    [No Abstract]   [Full Text] [Related]  

  • 12. Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador.
    Solis-Pazmino P; Salazar-Vega J; Lincango-Naranjo E; Garcia C; Koupermann GJ; Ortiz-Prado E; Ledesma T; Rojas T; Alvarado-Mafla B; Carcamo C; Ponce OJ; Brito JP
    BMC Cancer; 2021 Jan; 21(1):42. PubMed ID: 33419403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of differentiated thyroid cancer.
    Pacini F
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S492-6. PubMed ID: 12192551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of differentiated carcinoma of the thyroid gland].
    Mimura T; Ito K
    Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1184-9. PubMed ID: 9379097
    [No Abstract]   [Full Text] [Related]  

  • 15. The management of metastatic differentiated thyroid carcinoma.
    Sherman SI
    Rev Endocr Metab Disord; 2000 Apr; 1(3):165-71. PubMed ID: 11705002
    [No Abstract]   [Full Text] [Related]  

  • 16. [Malignant goiter--thyroid cancer].
    Reiners C; Dietlein M; Luster M
    Dtsch Med Wochenschr; 2008 Oct; 133(43):2215-28; quiz 2229-30. PubMed ID: 18924056
    [No Abstract]   [Full Text] [Related]  

  • 17. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Pacini F; Castagna MG; Brilli L; Pentheroudakis G;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii110-9. PubMed ID: 22997443
    [No Abstract]   [Full Text] [Related]  

  • 18. Well differentiated thyroid cancer.
    Caron NR; Clark OH
    Scand J Surg; 2004; 93(4):261-71. PubMed ID: 15658666
    [No Abstract]   [Full Text] [Related]  

  • 19. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
    Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
    Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differentiated thyroid carcinoma: initial evaluation and follow-up].
    Golbert L; Wajner SM; Rocha AP; Maia AL; Gross JL
    Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):701-10. PubMed ID: 16444352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.